Assyro AI

Orange Book product · Brand (NDA)

ALTABAX

RETAPAMULIN

Brand (NDA)NDA 022055DISCN ALMIRALL

At a glance

Apr 12, 2007

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 12, 2007

    19 yr 6 mo ago

  2. Today

  3. Patent 7875630 expires

    Listed drug substance patent expiration.

    Feb 14, 2027

    in 8 mo

Pharmaceutical detail

Active ingredient

RETAPAMULIN

Strength

1%

Dosage form

OINTMENT

Route

TOPICAL

TE code

Not listed

Application

NDA 022055

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7875630Feb 14, 2027in 8 mo
Substance
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.